{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:45:23Z","timestamp":1787755523094,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10549-024-07423-6","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T12:03:17Z","timestamp":1720440197000},"page":"349-358","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["A prospective study of vitamin D, proinflammatory cytokines, and risk of fragility fractures in women on aromatase inhibitors for breast cancer"],"prefix":"10.1007","volume":"208","author":[{"given":"Emily","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beshara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janise M.","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile A.","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Delmerico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan C.","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Chen","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine B.","family":"Ambrosone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence H.","family":"Kushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn L.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,8]]},"reference":[{"issue":"22","key":"7423_CR1","doi-asserted-by":"publisher","first-page":"5643","DOI":"10.3390\/cancers13225643","volume":"13","author":"N Nabieva","year":"2021","unstructured":"Nabieva N, Fasching PA (2021) Endocrine treatment for breast cancer patients revisited-history, standard of care, and possibilities of improvement. Cancers (Basel) 13(22):5643","journal-title":"Cancers (Basel)"},{"issue":"1","key":"7423_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1093\/jnci\/djx141","volume":"110","author":"H Goldvaser","year":"2018","unstructured":"Goldvaser H, Barnes TA, \u0160eruga B et al (2018) Toxicity of extended adjuvant therapy with aromatase inhibitors in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst 110(1):31","journal-title":"J Natl Cancer Inst"},{"key":"7423_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jbo.2017.03.001","volume":"7","author":"P Hadji","year":"2017","unstructured":"Hadji P, Aapro MS, Body JJ et al (2017) Management of aromatase inhibitor-associated bone loss (aibl) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG. J Bone Oncol 7:1\u201312","journal-title":"J Bone Oncol"},{"issue":"1","key":"7423_CR4","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s10549-019-05518-z","volume":"180","author":"S Yao","year":"2020","unstructured":"Yao S, Laurent CA, Roh JM et al (2020) Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study. Breast Cancer Res Treat 180(1):187\u2013195","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"7423_CR5","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/jbmr.5650110802","volume":"11","author":"R Pacifici","year":"1996","unstructured":"Pacifici R (1996) Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res 11(8):1043\u20131051","journal-title":"J Bone Miner Res"},{"issue":"1","key":"7423_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1742-7843.2008.00337.x","volume":"104","author":"L Folkestad","year":"2009","unstructured":"Folkestad L, Bjarnason NH, Bjerregaard JK, Brixen K (2009) The effect of aromatase inhibitors on bone metabolism. Basic Clin Pharmacol Toxicol 104(1):3\u201310","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"7423_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1136\/jcp.2010.086595","volume":"64","author":"S Jabbar","year":"2011","unstructured":"Jabbar S, Drury J, Fordham JN, Datta HK, Francis RM, Tuck SP (2011) Osteoprotegerin, RANKL and bone turnover in postmenopausal osteoporosis. J Clin Pathol 64(4):354\u2013357","journal-title":"J Clin Pathol"},{"issue":"10","key":"7423_CR8","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/intimm\/dxq431","volume":"22","author":"YM Lee","year":"2010","unstructured":"Lee YM, Fujikado N, Manaka H, Yasuda H, Iwakura Y (2010) IL-1 plays an important role in the bone metabolism under physiological conditions. Int Immunol 22(10):805\u2013816","journal-title":"Int Immunol"},{"issue":"4","key":"7423_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0154677","volume":"11","author":"X Li","year":"2016","unstructured":"Li X, Zhou ZY, Zhang YY, Yang HL (2016) IL-6 Contributes to the defective osteogenesis of bone marrow stromal cells from the vertebral body of the glucocorticoid-induced osteoporotic mouse. PLoS ONE 11(4):e0154677","journal-title":"PLoS ONE"},{"issue":"3","key":"7423_CR10","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s11914-017-0358-z","volume":"15","author":"B Zhao","year":"2017","unstructured":"Zhao B (2017) TNF and bone remodeling. Curr Osteoporos Rep 15(3):126\u2013134","journal-title":"Curr Osteoporos Rep"},{"issue":"10","key":"7423_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111477","volume":"9","author":"ML Kwan","year":"2014","unstructured":"Kwan ML, Lo JC, Tang L et al (2014) Bone health history in breast cancer patients on aromatase inhibitors. PLoS ONE 9(10):e111477","journal-title":"PLoS ONE"},{"issue":"3","key":"7423_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10549-016-4068-5","volume":"161","author":"S Yao","year":"2017","unstructured":"Yao S, Zhang Y, Tang L et al (2017) Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat 161(3):501\u2013513","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"7423_CR13","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10552-008-9170-5","volume":"19","author":"ML Kwan","year":"2008","unstructured":"Kwan ML, Ambrosone CB, Lee MM et al (2008) The pathways study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control 19(10):1065\u20131076","journal-title":"Cancer Causes Control"},{"key":"7423_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s11764-021-00993-0","author":"ML Kwan","year":"2021","unstructured":"Kwan ML, Lo JC, Laurent CA et al (2021) A prospective study of lifestyle factors and bone health in breast cancer patients who received aromatase inhibitors in an integrated healthcare setting. J Cancer Surv. https:\/\/doi.org\/10.1007\/s11764-021-00993-0","journal-title":"J Cancer Surv"},{"issue":"3","key":"7423_CR15","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1001\/jamaoncol.2016.4188","volume":"3","author":"S Yao","year":"2017","unstructured":"Yao S, Kwan ML, Ergas IJ et al (2017) Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study. JAMA Oncol 3(3):351\u2013357","journal-title":"JAMA Oncol"},{"issue":"11","key":"7423_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.33861","volume":"4","author":"JC Lo","year":"2021","unstructured":"Lo JC, Laurent CA, Roh JM et al (2021) Description of major osteoporotic fractures in women with invasive breast cancer who received endocrine therapy. JAMA Netw Open 4(11):e2133861","journal-title":"JAMA Netw Open"},{"key":"7423_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/782382","volume":"2015","author":"P Ruscitti","year":"2015","unstructured":"Ruscitti P, Cipriani P, Carubbi F et al (2015) The role of IL-1\u03b2 in the bone loss during rheumatic diseases. Mediat Inflamm 2015:782382","journal-title":"Mediat Inflamm"},{"issue":"2","key":"7423_CR18","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1172\/JCI200523394","volume":"115","author":"S Wei","year":"2005","unstructured":"Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL (2005) IL-1 mediates TNF-induced osteoclastogenesis. J Clin Invest 115(2):282\u2013290","journal-title":"J Clin Invest"},{"key":"7423_CR19","doi-asserted-by":"publisher","first-page":"48","DOI":"10.3389\/fimmu.2014.00048","volume":"5","author":"B Osta","year":"2014","unstructured":"Osta B, Benedetti G, Miossec P (2014) Classical and paradoxical effects of TNF-\u03b1 on bone homeostasis. Front Immunol 5:48","journal-title":"Front Immunol"},{"issue":"1","key":"7423_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10067-019-04771-3","volume":"39","author":"K Guly\u00e1s","year":"2020","unstructured":"Guly\u00e1s K, Horv\u00e1th \u00c1, V\u00e9gh E et al (2020) Effects of 1-year anti-TNF-\u03b1 therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 39(1):167\u2013175","journal-title":"Clin Rheumatol"},{"issue":"9","key":"7423_CR21","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1359\/jbmr.2003.18.9.1584","volume":"18","author":"LC Gerstenfeld","year":"2003","unstructured":"Gerstenfeld LC, Cho TJ, Kon T et al (2003) Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 18(9):1584\u20131592","journal-title":"J Bone Miner Res"},{"key":"7423_CR22","volume":"2013","author":"MN Weitzmann","year":"2013","unstructured":"Weitzmann MN (2013) The role of inflammatory cytokines, the RANKL\/OPG axis, and the immunoskeletal interface in physiological bone turnover and osteoporosis. Scientifica (Cairo) 2013:125705","journal-title":"Scientifica (Cairo)"},{"issue":"1\u20132","key":"7423_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.mce.2011.05.038","volume":"347","author":"S Christakos","year":"2011","unstructured":"Christakos S, Dhawan P, Porta A, Mady LJ, Seth T (2011) Vitamin D and intestinal calcium absorption. Mol Cell Endocrinol 347(1\u20132):25\u201329","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"7423_CR24","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1172\/JCI29449","volume":"116","author":"MF Holick","year":"2006","unstructured":"Holick MF (2006) Resurrection of vitamin D deficiency and rickets. J Clin Invest 116(8):2062\u20132072","journal-title":"J Clin Invest"},{"issue":"4","key":"7423_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.beem.2011.05.002","volume":"25","author":"P Lips","year":"2011","unstructured":"Lips P, van Schoor NM (2011) The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab 25(4):585\u2013591","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"7","key":"7423_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1056\/NEJMoa055218","volume":"354","author":"RD Jackson","year":"2006","unstructured":"Jackson RD, LaCroix AZ, Gass M et al (2006) Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 354(7):669\u2013683","journal-title":"N Engl J Med"},{"issue":"13","key":"7423_CR27","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1056\/NEJM199009273231305","volume":"323","author":"B Dawson-Hughes","year":"1990","unstructured":"Dawson-Hughes B, Dallal GE, Krall EA, Sadowski L, Sahyoun N, Tannenbaum S (1990) A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323(13):878\u2013883","journal-title":"N Engl J Med"},{"issue":"7","key":"7423_CR28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1056\/NEJM199302183280702","volume":"328","author":"IR Reid","year":"1993","unstructured":"Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ (1993) Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med 328(7):460\u2013464","journal-title":"N Engl J Med"},{"issue":"10","key":"7423_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1056\/NEJM199709043371003","volume":"337","author":"B Dawson-Hughes","year":"1997","unstructured":"Dawson-Hughes B, Harris SS, Krall EA, Dallal GE (1997) Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 337(10):670\u2013676","journal-title":"N Engl J Med"},{"issue":"23","key":"7423_CR30","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","volume":"327","author":"MC Chapuy","year":"1992","unstructured":"Chapuy MC, Arlot ME, Duboeuf F et al (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327(23):1637\u20131642","journal-title":"N Engl J Med"},{"issue":"3","key":"7423_CR31","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1359\/JBMR.0301240","volume":"19","author":"ER Larsen","year":"2004","unstructured":"Larsen ER, Mosekilde L, Foldspang A (2004) Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 19(3):370\u2013378","journal-title":"J Bone Miner Res"},{"issue":"9","key":"7423_CR32","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1359\/jbmr.1997.12.9.1321","volume":"12","author":"RG Cumming","year":"1997","unstructured":"Cumming RG, Nevitt MC (1997) Calcium for prevention of osteoporotic fractures in postmenopausal women. J Bone Miner Res 12(9):1321\u20131329","journal-title":"J Bone Miner Res"},{"issue":"9471","key":"7423_CR33","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1016\/S0140-6736(05)63013-9","volume":"365","author":"AM Grant","year":"2005","unstructured":"Grant AM, Avenell A, Campbell MK et al (2005) Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (randomised evaluation of calcium Or vitamin D, record): a randomised placebo-controlled trial. Lancet 365(9471):1621\u20131628","journal-title":"Lancet"},{"issue":"7498","key":"7423_CR34","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1136\/bmj.330.7498.1003","volume":"330","author":"J Porthouse","year":"2005","unstructured":"Porthouse J, Cockayne S, King C et al (2005) Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 330(7498):1003","journal-title":"BMJ"},{"issue":"24","key":"7423_CR35","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1001\/jama.2017.19344","volume":"318","author":"JG Zhao","year":"2017","unstructured":"Zhao JG, Zeng XT, Wang J, Liu L (2017) Association between calcium or vitamin d supplementation and fracture incidence in community-dwelling older adults: a systematic review and meta-analysis. JAMA 318(24):2466\u20132482","journal-title":"JAMA"},{"issue":"18","key":"7423_CR36","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1001\/jama.2010.594","volume":"303","author":"KM Sanders","year":"2010","unstructured":"Sanders KM, Stuart AL, Williamson EJ et al (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303(18):1815\u20131822","journal-title":"JAMA"},{"issue":"1","key":"7423_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJMe1206858","volume":"367","author":"RP Heaney","year":"2012","unstructured":"Heaney RP (2012) Vitamin D\u2013baseline status and effective dose. N Engl J Med 367(1):77\u201378","journal-title":"N Engl J Med"},{"key":"7423_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h4580","volume":"351","author":"MJ Bolland","year":"2015","unstructured":"Bolland MJ, Leung W, Tai V et al (2015) Calcium intake and risk of fracture: systematic review. BMJ 351:h4580","journal-title":"BMJ"},{"issue":"15","key":"7423_CR39","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1001\/jama.2018.3185","volume":"319","author":"DC Grossman","year":"2018","unstructured":"US Preventive Services Task Force, Grossman DC, Curry SJ et al (2018) Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: US preventive services task force recommendation statement. JAMA 319(15):1592\u20131599","journal-title":"JAMA"},{"issue":"15","key":"7423_CR40","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1001\/jama.2017.21640","volume":"319","author":"LC Kahwati","year":"2018","unstructured":"Kahwati LC, Weber RP, Pan H et al (2018) Vitamin D, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: evidence report and systematic review for the US preventive services task force. JAMA 319(15):1600\u20131612","journal-title":"JAMA"},{"issue":"1","key":"7423_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10549-011-1644-6","volume":"129","author":"AL Rastelli","year":"2011","unstructured":"Rastelli AL, Taylor ME, Gao F et al (2011) Vitamin D and aromatase inhibitor-induced musculoskeletal symptoms (AIMSS): a phase II, double-blind, placebo-controlled, randomized trial. Breast Cancer Res Treat 129(1):107\u2013116","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"7423_CR42","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s10549-010-1075-9","volume":"125","author":"D Prieto-Alhambra","year":"2011","unstructured":"Prieto-Alhambra D, Javaid MK, Servitja S et al (2011) Vitamin D threshold to prevent aromatase inhibitor-induced arthralgia: a prospective cohort study. Breast Cancer Res Treat 125(3):869\u2013878","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"7423_CR43","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/01.NCC.0000339262.44560.92","volume":"32","author":"NL Waltman","year":"2009","unstructured":"Waltman NL, Ott CD, Twiss JJ, Gross GJ, Lindsey AM (2009) Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy. Cancer Nurs 32(2):143\u2013150","journal-title":"Cancer Nurs"},{"issue":"3","key":"7423_CR44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10549-016-3710-6","volume":"155","author":"AC Shapiro","year":"2016","unstructured":"Shapiro AC, Adlis SA, Robien K et al (2016) Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS). Breast Cancer Res Treat 155(3):501\u2013512","journal-title":"Breast Cancer Res Treat"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07423-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10549-024-07423-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-024-07423-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T21:02:53Z","timestamp":1728162173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10549-024-07423-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,8]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7423"],"URL":"https:\/\/doi.org\/10.1007\/s10549-024-07423-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,8]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}